Abstract:Purpose: PHF21A has been associated with intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures (IDDBCS). Here, we report a new patient with IDDBCS and review previously reported patients. Methods: We reviewed the phenotypic and genetic spectrum of the newly diagnosed patient and previously reported patients with IDDBCS. Results: Among 12 patients (11 whose cases were previously reported and the patient whose case we report here), all patients (100%) had intellectual disability (ID) and motor development delay. Three of 8 patients (37.5%) for whom information on cognition was available had severe ID; ID was moderate in two patients (25%) and mild in three patients (37.5%). Seven of the 12 patients (58.33%) had an epileptic phenotype, and the majority (5/7, 71.42%) of affected individuals developed developmental and epileptic encephalopathy (DEE). Of the 5 patients with DEE, three developed infantile epileptic spasm syndrome (IESS). The seizures of 2 patients (2/5, 40%) were controlled by antiseizure medications. Overgrowth, ADHD, hypotonia, ASD, and sleep disorders were observed in 100%, 77.78%, 70%, 50%, and 33.33% of patients, respectively. All of the variants (100%) were de novo heterozygous variants. Three of the 12 patients (25%) had the same variant (p.Arg580*). The most common types of variants were frameshift variants (7/12, 58.33%), followed by nonsense variants (4/12, 33.33%) and missense variants (1/12, 8.33%). Genotype-phenotype relationships for IDDBCS were uncertain, as phenotypic variability was observed among patients with the same variant (p.Arg580*). The patient whose case we report here had a novel PHF21A gene variant (p.Gln97fs*20), which caused neurodevelopmental delay, macrocephaly, and IESS. Conclusion: The core phenotypes of IDDBCS include neurodevelopmental delay (intellectual disability and impaired motor skills), craniofacial abnormalities, and overgrowth. ADHD, hypotonia, epilepsy, ASD, and sleep disorders are common symptoms of IDDBCS. Notably, DEE is the dominant phenotype of epilepsy, especially IESS. PHF21A may be a candidate gene for DEE. De novo variants are the main mode of inheritance. The most common types of variants are frameshift variants, and the variant p.Arg580* in PHF21A is located at a mutation hot spot.

Phenotype of heterozygous variants of dehydrodolichol diphosphate synthase

DHDDS and NUS1: A Converging Pathway and Common Phenotype

Case report: Identification of a recurrent pathogenic DHDDS mutation in Chinese family with epilepsy, intellectual disability and myoclonus

A Novel Variant of the CHD2 Gene Associated With Developmental Delay and Myoclonic Epilepsy

DHDDS-related disease; biallelic missense novel variant causing major severity with an early-onset epilepsy and hyperkinetic movement disorder

Assessing age of onset and clinical symptoms over time in patients with heterozygous pathogenic DHDDS variants

[Genotype and Phenotype of Female Dravet Syndrome with PCDH19 Mutations].

Phenotypic and genotypic characteristics of children with PCDH19 clustering epilepsy in China

Genetic Variants and Phenotype Analysis in a Five-Generation Chinese Pedigree with PCDH19 Female-Limited Epilepsy.

[Genotype and Phenotype of Children with DEPDC5 Gene Variants Related Epilepsy].

DLG3 variants caused X-linked epilepsy with/without neurodevelopmental disorders and the genotype-phenotype correlation

De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review

DYNC1H1‐related Epilepsy: Genotype–phenotype Correlation

DEPDC5 Variants Associated Malformations of Cortical Development and Focal Epilepsy With Febrile Seizure Plus/Febrile Seizures: The Role of Molecular Sub-Regional Effect

CHD2‐related Epilepsy: Novel Mutations and New Phenotypes

The clinical spectrum of female epilepsy patients with PCDH19 mutations in a Chinese population

Early Onset Developmental Delay and Epilepsy in Pediatric Patients with WDR45 Variants.

<i>SZT2</i> variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation

A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity

PCDH19-related epilepsy in mosaic males: The phenotypic implication of genotype and variant allele frequency

A homozygous founder variant in PDE2A causes paroxysmal dyskinesia with intellectual disability